IGNITE KUH Professional Development Core
IGNITE KUH 专业发展核心
基本信息
- 批准号:10285528
- 负责人:
- 金额:$ 0.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-16 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressApplications GrantsAreaAwardBasic ScienceBiomedical ResearchCareer MobilityClinical ResearchCommunicationContinuing EducationDevelopmentDevelopment PlansEducationEducational process of instructingEducational workshopEmerging TechnologiesEnsureEntrepreneurshipEvaluationExposure toFacultyFosteringFutureHematologyIndividualInstitutionIntellectual PropertyKidneyLeadershipLearningMedicalMedicineMentorsMethodologyOnline SystemsOralParticipantPatientsPersonsPostdoctoral FellowProgram DevelopmentResearchResearch TrainingResource DevelopmentResourcesScienceScientistSeriesStudentsTechnical ExpertiseTechnologyTrainingTraining ProgramsUniversitiesUrologyVirginiaWritingcareercareer developmentcareer networkingcommunication aiddesigneducation researchexperienceimprovedinnovationlecturespandemic diseasepre-doctoralproduct developmentprogramsrecruitremediationresponseskill acquisitionskillsstrength trainingsuccesssymposiumtelehealth
项目摘要
PROFESSIONAL DEVELOPMENT CORE ABSTRACT
The University of Virginia (UVA), Virginia Commonwealth University (VCU) and Virginia Tech (VT), each have
well developed Professional Development programs for pre- and post-doctoral trainees participating in basic or
translational biomedical research. However, educational opportunities in KUH generally are sparse. This
proposal addresses this deficiency. We plan to take advantage of the particular strengths of each institution and
the revolution in web-based conferencing in response to the pandemic to help create an effective multi-
institutional training program. The majority of classes and seminars offered to our trainees will be both in person
and on-line, so that the institutional strengths can be shared by all. Hence, the inclusion of three primary
institutions as well as other participants serves as a strength, rather than a weakness of the training program.
An advantage of the heavy emphasis on web-based conferencing is that it will familiarize trainees with the
technologies that are the wave of the future in science and medicine. Another point of emphasis in our
professional development plan is intellectual property education. Aim 1: To teach trainees skills that enable
them to tackle all aspects of career development. These include effective written and oral presentations;
enhancing overall communication skills; and developing an effective professional network. Trainees will be
immersed in a team science approach to aid in networking and exposure to cutting-edge technologies including
on-line communication. Aim 2: To provide trainees with mentoring skills and to improve the mentoring
skills of preceptors. Mentoring will include formal didactic training and informal basic and clinical research
training. The program will avail preceptors with teaching forums and trainee evaluations in order to improve
mentoring.
专业发展核心摘要
弗吉尼亚大学(UVA),弗吉尼亚联邦大学(VCU)和弗吉尼亚理工大学(VT),每个都有
完善的专业发展计划,为前和博士后学员参加基本或
转化生物医学研究然而,KUH的教育机会通常很少。这
提案解决了这一缺陷。我们计划利用每个机构的特殊优势,
为应对这一流行病而进行的基于网络的会议革命,
机构培训计划。我们为学员提供的大部分课程和研讨会都是亲自参加的,
和在线,以便所有人都能分享机构的优势。因此,包括三个主要的
机构以及其他参与者的参与是培训计划的优势,而不是弱点。
着重强调网络会议的一个好处是,它将使受训者熟悉
这些技术是未来科学和医学的潮流。我们的另一个重点是
专业发展计划是知识产权教育。目标1:向学员传授技能,
以解决职业发展的各个方面。这些包括有效的书面和口头陈述;
提高整体沟通技巧;发展有效的专业网络。学员将
沉浸在团队科学的方法,以帮助网络和接触尖端技术,包括
在线交流目标2:向受训者提供辅导技能并改进辅导
教师的技能。指导将包括正式的教学培训和非正式的基础和临床研究
训练该计划将利用导师与教学论坛和学员评估,以提高
指导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel M. Linden其他文献
Joel M. Linden的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel M. Linden', 18)}}的其他基金
Lymphocyte Activation in Sickle Cell Lung Disease
镰状细胞性肺病中的淋巴细胞激活
- 批准号:
8269732 - 财政年份:2010
- 资助金额:
$ 0.49万 - 项目类别:
Lymphocyte Activation in Sickle Cell Lung Disease
镰状细胞性肺病中的淋巴细胞激活
- 批准号:
8656737 - 财政年份:2010
- 资助金额:
$ 0.49万 - 项目类别:
Lymphocyte Activation in Sickle Cell Lung Disease
镰状细胞性肺病中的淋巴细胞激活
- 批准号:
7784622 - 财政年份:2010
- 资助金额:
$ 0.49万 - 项目类别:
Lymphocyte Activation in Sickle Cell Lung Disease
镰状细胞性肺病中的淋巴细胞激活
- 批准号:
8067086 - 财政年份:2010
- 资助金额:
$ 0.49万 - 项目类别:
Lymphocyte Activation in Sickle Cell Lung Disease
镰状细胞性肺病中的淋巴细胞激活
- 批准号:
8462663 - 财政年份:2010
- 资助金额:
$ 0.49万 - 项目类别:
CTRIP: Treatment of Sickle Cell Crisis with inhibitors of NKT cell activation
CTRIP:用 NKT 细胞活化抑制剂治疗镰状细胞危机
- 批准号:
7852702 - 财政年份:2009
- 资助金额:
$ 0.49万 - 项目类别:
CTRIP: Treatment of Sickle Cell Crisis with inhibitors of NKT cell activation
CTRIP:用 NKT 细胞活化抑制剂治疗镰状细胞危机
- 批准号:
7940964 - 财政年份:2009
- 资助金额:
$ 0.49万 - 项目类别:
Molecular and Cellular Targets of Adenosine in Lung
肺中腺苷的分子和细胞靶标
- 批准号:
7415116 - 财政年份:2007
- 资助金额:
$ 0.49万 - 项目类别:
Molecular and Cellular Targets of Adenosine in Lung
肺中腺苷的分子和细胞靶标
- 批准号:
7232629 - 财政年份:2006
- 资助金额:
$ 0.49万 - 项目类别:














{{item.name}}会员




